Lymphoma

Showing NaN - NaN of 69

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Reserve in Younger Newly Diagnosed Lymphomas

Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
Jan 11, 2023

Solid Tumors, Lymphoma Trial in Worldwide (ASTX660)

Active, not recruiting
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +68 more
Nov 18, 2022

Lymphoma Trial in United States (biological, drug, radiation)

Active, not recruiting
  • Lymphoma
  • rituximab
  • +5 more
  • Anchorage, Alaska
  • +258 more
Sep 23, 2022

Lymphoma, Acute Lymphoblastic Leukemia, Pediatric Cancer Trial in Richmond (Intravenous fluids)

Recruiting
  • Lymphoma
  • +4 more
  • Intravenous fluids
  • Richmond, Virginia
    Virginia Commonwealth University/ Massey Cancer Center/ Children
Aug 25, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)

Completed
  • Lymphoma
  • Nonneoplastic Condition
  • bleomycin sulfate
  • +11 more
  • Tucson, Arizona
  • +422 more
Aug 16, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Lymphoma, Leukemia Trial in Australia, China (Zanubrutinib, Tislelizumab)

Completed
  • Lymphoma
  • Leukemia
  • Darlinghurst, New South Wales, Australia
  • +9 more
Mar 16, 2022

Breast Cancer, Lymphoma Trial in United States (Atorvastatin, Placebo)

Completed
  • Breast Cancer
  • Lymphoma
  • Los Angeles, California
  • +50 more
Dec 6, 2021

Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)

Active, not recruiting
  • Hodgkin's Lymphoma
  • +17 more
  • mycophenolate mofetil
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Dec 21, 2021

Lymphoma Trial in United States (ABVD, BEACOPP, radiation therapy)

Completed
  • Lymphoma
  • Saint Helena, California
  • +54 more
Nov 5, 2021

Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
  • +5 more
  • Birmingham, Alabama
  • +38 more
Oct 25, 2021

Lymphoma Trial in United States (rituximab, bendamustine HCl, cyclophosphamide)

Completed
  • Lymphoma
  • rituximab
  • +8 more
  • Duarte, California
  • +203 more
Oct 14, 2021

Lymphoma Trial in United States (ofatumumab)

Completed
  • Lymphoma
  • ofatumumab
  • Lewes, Delaware
  • +47 more
Aug 16, 2021

Lymphoma Trial in United States (carmustine, cytarabine, etoposide)

Active, not recruiting
  • Lymphoma
  • Anchorage, Alaska
  • +125 more
Aug 16, 2021

Lymphoma Trial in United States (biological, drug, radiation, procedure)

Completed
  • Lymphoma
  • Bleomycin Sulfate
  • +11 more
  • Tucson, Arizona
  • +94 more
Jun 10, 2021

Leukemia, Lymphoma, GVHD Trial in Australia, United States (cyclosporine, cyclosporine and methotrexate)

Terminated
  • Leukemia
  • +2 more
  • Los Angeles, California
  • +12 more
May 3, 2021

Lymphoma Trial in United States (enzastaurin, rituximab, cyclophosphamide)

Completed
  • Lymphoma
  • Huntsville, Alabama
  • +24 more
Jul 20, 2020

Leukemia, Lymphoma Trial in Canada, United States (biological, drug, procedure, radiation)

Terminated
  • Leukemia
  • Lymphoma
  • therapeutic allogeneic lymphocytes
  • +8 more
  • Denver, Colorado
  • +22 more
Apr 8, 2020

Myeloma, Lymphoma, Leukemia Trial in Richmond (EMR Tailoring, Survey Tailoring, Physician Involvement)

Completed
  • Myeloma
  • +2 more
  • EMR Tailoring
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Mar 31, 2020

Lymphoma Trial in Australia, United States (RP4010)

Terminated
  • Lymphoma
  • Birmingham, Alabama
  • +10 more
Dec 26, 2019

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

Withdrawn
  • Leukemia
  • +4 more
  • alemtuzumab
  • +6 more
  • La Jolla, California
  • +23 more
Nov 25, 2019

Lymphoma Trial in United States (epratuzumab, rituximab, cyclophosphamide)

Completed
  • Lymphoma
  • epratuzumab
  • +5 more
  • Scottsdale, Arizona
  • +161 more
Oct 1, 2019

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

Completed
  • Leukemia
  • +4 more
  • therapeutic allogeneic lymphocytes
  • +6 more
  • Denver, Colorado
  • +13 more
Sep 13, 2019

Lymphoma Trial in United States (biological, drug, radiation)

Completed
  • Lymphoma
  • rituximab
  • +5 more
  • Mobile, Alabama
  • +113 more
Aug 15, 2019